info@mediysresearch.org
718 206 6000
Home
Published Work
Poster Presentations
PI Projects
Clinical Trials
Contact
Clinical Trials
Home
Clinical Trials
Thursday 5th May 2022
A randomized, controlled, multi-center, open-label trial comparing a hospital, post-discharge care pathway involving aggressive LDL-C management that includes inclisiran with usual care versus usual care alone in patients with a recent coronary syndrome
Tuesday 11th January 2022
Phase 1B/2A, randomized, double-blind, placebo-controlled, multiple ascending dose escalation study of the safety, tolerability, and efficacy of intravenous AP-SA02 as an adjunct to best available therapy alone for the treatment of adults with bacteremia due to Staphylococcus aureus.
Friday 14th August 2020
Phase 3 Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID)
Tuesday 5th May 2020
A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19.
Friday 1st May 2020
A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia (MARIPOSA)
Sunday 22nd March 2020
A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants with Severe COVID-19
Saturday 22nd February 2020
A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734TM) in Participants with Moderate COVID-19 Compared to Standard of Care Treatment
Monday 4th November 2019
RANDOMIZED, CONTROLLED, MULTI-CENTER STUDY TO ASSESS THE EFFICACY, SAFETY, AND TOLERABILITY OF INTRAVITREAL AFLIBERCEPT COMPARED TO LASER PHOTOCOAGULATION IN PATIENTS WITH RETINOPATHY OF PREMATURITY (BUTTERFLEYE)
Monday 9th September 2019
Women’s Ischemia Trial to Reduce Events in Non-Obstructive CAD (WARRIOR)
Tuesday 5th June 2018
Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
Tuesday 6th March 2018
Streamlining Trauma Research Evaluation With Advanced Measurement (STREAM)
Tuesday 6th June 2017
Blood Sample Collection in Subjects with Pulmonary Nodules or CT Suspicion of Lung Cancer
Friday 26th October 2012
A Prospective Randomized Trial to Assess PO Versus IV Antibiotics for the Treatment of Post-op Wound Infection After Extremity Fractures (POvIV)
Friday 25th May 2012
Outcomes Following Severe Distal Tibia, Ankle and/or Foot Trauma: Comparison of Limb Salvage Versus Transtibial Amputation Protocol (OUTLET)